Maxcyte (MXCT) Total Non-Current Liabilities (2020 - 2026)

Maxcyte (MXCT) has 7 years of Total Non-Current Liabilities data on file, last reported at $26.3 million in Q1 2026.

• On a quarterly basis, Total Non-Current Liabilities fell 13.06% year-over-year to $26.3 million in Q1 2026; TTM through Mar 2026 was $26.3 million, a 13.06% decrease from a year earlier, with the FY2025 full-year figure at $30.8 million, down 6.65% from the prior year.
• Total Non-Current Liabilities for Q1 2026 stood at $26.3 million, down from $30.8 million in the prior quarter.
• Over the last five years, Total Non-Current Liabilities for MXCT reached as high as $35.8 million in Q4 2023 and fell as low as $26.3 million in Q1 2026.
• Historically, Total Non-Current Liabilities has averaged $31.2 million across 5 years, with a median of $31.3 million in 2022.
• Across the five-year window, Total Non-Current Liabilities jumped 144.74% in 2022 and decreased 13.06% in 2026, its largest moves.
• Year by year, Total Non-Current Liabilities stood at $31.4 million in 2022, then increased by 14.22% to $35.8 million in 2023, then fell by 8.04% to $32.9 million in 2024, then fell by 6.65% to $30.8 million in 2025, then slipped by 14.4% to $26.3 million in 2026.
• Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $26.3 million in Q1 2026, $30.8 million in Q4 2025, and $33.0 million in Q3 2025.